Brian Mahoney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brian Mahoney has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Henrique Gomes Martins
Federal University of Uberlândia
1 shared publication - David Philip Day
Department of Chemistry, University of Warwick, Coventry, CV4 7AL, U.K.
1 shared publication - Jairo Kenupp Bastos
School of Pharmaceutical Sciences of Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14040-903, SP, Brazil
1 shared publication - Mirela M. W. Cabral
Pesquisas em Ciências Exatas e Tecnológicas, Universidade de Franca, Franca 14404-600, Brazil
1 shared publication - Philip Charles Bulman Page
School of Chemistry, University of East Anglia, Norwich NR4 7TJ, UK
1 shared publication - Priscilla Mendonça Matos
Núcleo de Pesquisas em Ciências Exatas e Tecnológicas, Universidade de Franca, Franca, SP, Brazil
1 shared publication
Latest Publications
- Open Access
New Non-Toxic Semi-Synthetic Derivatives from Natural Diterpenes Displaying Anti-Tuberculosis Activity
We report herein the synthesis of six diterpene derivatives, three of which are new, generated through known organic chemistry reactions that allowed structural modification of the existing natural products kaurenoic acid (1) and copalic acid (2). The new compounds were fully characterized using high resolution mass spectrometry, infrared spectroscopy, 1H- and 13C-NMR experiments. We also report the evaluation of the anti-tuberculosis potential for all compounds, which showed some promising results for Micobacterium tuberculosis inhibition. Moreover, the toxicity for each of the most active compounds was also assessed.
Open AccessNew Non-Toxic Semi-Synthetic Derivatives from Natural Diterpenes Displaying Anti-Tuberculosis Activity
We report herein the synthesis of six diterpene derivatives, three of which are new, generated through known organic chemistry reactions that allowed structural modification of the existing natural products kaurenoic acid (1) and copalic acid (2). The new compounds were fully characterized using high resolution mass spectrometry, infrared spectroscopy, 1H- and 13C-NMR experiments. We also report the evaluation of the anti-tuberculosis potential for all compounds, which showed some promising results for Micobacterium tuberculosis inhibition. Moreover, the toxicity for each of the most active compounds was also assessed.